Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing innovative products for patients living with debilitating diseases.

How We’re Helping Patients

Latest News

December 12, 2019 • 12:00am EST

Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares

Read Press Release View All News

December 9, 2019 • 12:00am EST

Aurinia Prices US$166.7 Million Public Offering of Common Shares

Read Press Release View All News

December 9, 2019 • 12:00am EST

Aurinia Announces Public Offering of Common Shares

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today